Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1161/CIR.0000000000001038 | DOI Listing |
Cardiovasc Revasc Med
April 2024
Hospital do Coração, HCor, São Paulo, Brazil.
Coronary artery bypass (CABG) has evolved over the decades, supported by scientific evidence from robust studies. The downgrade of the recommendation for CABG in patients with multivessel coronary artery disease proposed by the 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization and the 2023 ACC/AHA Chronic Coronary Disease Guidelines has brought this discussion to the fore, with prestigious cardiothoracic surgery societies such as AATS and STS not supporting these recommendations. The purpose of this article is to broaden this discussion in light of published studies.
View Article and Find Full Text PDFBraz J Cardiovasc Surg
April 2024
Cardiovascular Surgery Discipline, Hospital São Paulo, Escola Paulista de Medicina, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil.
Braz J Cardiovasc Surg
October 2023
Centro Cardiovascular Universitario, Universidad de la Republica del Uruguay, Montevideo, Uruguay.
Cureus
July 2023
Department of Internal Medicine, Jinnah Hospital, Lahore, PAK.
Percutaneous coronary intervention (PCI) is a widely used therapy for coronary artery disease (CAD), but it carries risks and complications. Adhering to evidence-based practice guidelines is crucial for optimal outcomes. This review compares the recommendations of the 2021 American College of Cardiology/American Heart Association/Society for Cardiovascular Angiography and Interventions (ACC/AHA/SCAI) and 2018 European Society of Cardiology (ESC) guidelines for coronary artery revascularization and discusses emerging trends and novel devices in PCI.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!